company background image
REME

Remedy Entertainment OyjHLSE:REMEDY Stock Report

Market Cap

€497.4m

7D

-5.2%

1Y

10.0%

Updated

07 Dec, 2021

Data

Company Financials +
REMEDY fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health5/6
Dividends0/6

REMEDY Stock Overview

Remedy Entertainment Oyj develops and sells console and computer games in Finland and internationally.

Remedy Entertainment Oyj Competitors

Tencent Holdings

SEHK:700

HK$4.4t

Price History & Performance

Summary of all time highs, changes and price drops for Remedy Entertainment Oyj
Historical stock prices
Current Share Price€37.40
52 Week High€49.90
52 Week Low€31.20
Beta0.17
1 Month Change-11.58%
3 Month Change-10.95%
1 Year Change10.00%
3 Year Change434.29%
5 Year Changen/a
Change since IPO459.04%

Recent News & Updates

May 22
Do Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Warrant Your Attention?

Do Remedy Entertainment Oyj's (HEL:REMEDY) Earnings Warrant Your Attention?

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...

May 04
Estimating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)

Estimating The Intrinsic Value Of Remedy Entertainment Oyj (HEL:REMEDY)

Today we will run through one way of estimating the intrinsic value of Remedy Entertainment Oyj ( HEL:REMEDY ) by...

Shareholder Returns

REMEDYFI EntertainmentFI Market
7D-5.2%-1.7%-1.1%
1Y10.0%-13.6%10.4%

Return vs Industry: REMEDY exceeded the Finnish Entertainment industry which returned -14.6% over the past year.

Return vs Market: REMEDY exceeded the Finnish Market which returned 11% over the past year.

Price Volatility

Is REMEDY's price volatile compared to industry and market?
REMEDY volatility
REMEDY Average Weekly Movement5.0%
Entertainment Industry Average Movement6.3%
Market Average Movement4.6%
10% most volatile stocks in FI Market6.8%
10% least volatile stocks in FI Market3.0%

Stable Share Price: REMEDY is not significantly more volatile than the rest of Finnish stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: REMEDY's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1995293Tero Virtalahttps://www.remedygames.com

Remedy Entertainment Oyj develops and sells console and computer games in Finland and internationally. It primarily creates cinematic action games. The company was incorporated in 1995 and is based in Espoo, Finland.

Remedy Entertainment Oyj Fundamentals Summary

How do Remedy Entertainment Oyj's earnings and revenue compare to its market cap?
REMEDY fundamental statistics
Market Cap€497.36m
Earnings (TTM)€9.48m
Revenue (TTM)€48.76m

52.4x

P/E Ratio

10.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
REMEDY income statement (TTM)
Revenue€48.76m
Cost of Revenue€6.52m
Gross Profit€42.24m
Expenses€32.76m
Earnings€9.48m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.71
Gross Margin86.62%
Net Profit Margin19.45%
Debt/Equity Ratio4.8%

How did REMEDY perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

20%

Payout Ratio

Valuation

Is Remedy Entertainment Oyj undervalued compared to its fair value and its price relative to the market?

30.1%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: REMEDY (€37.8) is trading below our estimate of fair value (€54.58)

Significantly Below Fair Value: REMEDY is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: REMEDY is poor value based on its PE Ratio (53x) compared to the European Entertainment industry average (23.4x).

PE vs Market: REMEDY is poor value based on its PE Ratio (53x) compared to the Finnish market (22.7x).


Price to Earnings Growth Ratio

PEG Ratio: REMEDY is poor value based on its PEG Ratio (2x)


Price to Book Ratio

PB vs Industry: REMEDY is overvalued based on its PB Ratio (6.6x) compared to the XE Entertainment industry average (3.5x).


Future Growth

How is Remedy Entertainment Oyj forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

26.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: REMEDY's forecast earnings growth (26.3% per year) is above the savings rate (0.2%).

Earnings vs Market: REMEDY's earnings (26.3% per year) are forecast to grow faster than the Finnish market (3.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: REMEDY's revenue (17.4% per year) is forecast to grow faster than the Finnish market (3.6% per year).

High Growth Revenue: REMEDY's revenue (17.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if REMEDY's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Remedy Entertainment Oyj performed over the past 5 years?

49.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: REMEDY has a high level of non-cash earnings.

Growing Profit Margin: REMEDY's current net profit margins (19.4%) are higher than last year (17.3%).


Past Earnings Growth Analysis

Earnings Trend: REMEDY's earnings have grown significantly by 49.7% per year over the past 5 years.

Accelerating Growth: REMEDY's earnings growth over the past year (44.4%) is below its 5-year average (49.7% per year).

Earnings vs Industry: REMEDY earnings growth over the past year (44.4%) exceeded the Entertainment industry 32.4%.


Return on Equity

High ROE: REMEDY's Return on Equity (12.4%) is considered low.


Financial Health

How is Remedy Entertainment Oyj's financial position?


Financial Position Analysis

Short Term Liabilities: REMEDY's short term assets (€75.2M) exceed its short term liabilities (€9.8M).

Long Term Liabilities: REMEDY's short term assets (€75.2M) exceed its long term liabilities (€2.8M).


Debt to Equity History and Analysis

Debt Level: REMEDY has more cash than its total debt.

Reducing Debt: REMEDY's debt to equity ratio has increased from 1.8% to 4.8% over the past 5 years.

Debt Coverage: REMEDY's debt is well covered by operating cash flow (372%).

Interest Coverage: REMEDY's interest payments on its debt are well covered by EBIT (9.6x coverage).


Balance Sheet


Dividend

What is Remedy Entertainment Oyj current dividend yield, its reliability and sustainability?

0.40%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: REMEDY's dividend (0.4%) isn’t notable compared to the bottom 25% of dividend payers in the Finnish market (1.7%).

High Dividend: REMEDY's dividend (0.4%) is low compared to the top 25% of dividend payers in the Finnish market (3.73%).


Stability and Growth of Payments

Stable Dividend: REMEDY is not paying a notable dividend for the Finnish market, therefore no need to check if payments are stable.

Growing Dividend: REMEDY is not paying a notable dividend for the Finnish market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: REMEDY is not paying a notable dividend for the Finnish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of REMEDY's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.9yrs

Average management tenure


CEO

Tero Virtala (47 yo)

5.92yrs

Tenure

Mr. Tero Virtala has been Chief Executive Officer at Remedy Entertainment Oyj since 2016. Mr. Virtala served as the Chief Executive Officer and Managing Director of Redlynx, Ltd. He serves as a Director of...


Leadership Team

Experienced Management: REMEDY's management team is seasoned and experienced (5.9 years average tenure).


Board Members

Experienced Board: REMEDY's board of directors are considered experienced (5.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.


Top Shareholders

Company Information

Remedy Entertainment Oyj's employee growth, exchange listings and data sources


Key Information

  • Name: Remedy Entertainment Oyj
  • Ticker: REMEDY
  • Exchange: HLSE
  • Founded: 1995
  • Industry: Interactive Home Entertainment
  • Sector: Media
  • Market Cap: €497.362m
  • Shares outstanding: 13.30m
  • Website: https://www.remedygames.com

Number of Employees


Location

  • Remedy Entertainment Oyj
  • Luomanportti 3
  • Espoo
  • Uusimaa
  • 2200
  • Finland

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/07 23:07
End of Day Share Price2021/12/07 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.